Iovance Biotherapeutics, Inc. IOVA Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s gain (loss) on disposition of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s gain (loss) on disposition of assets?
- Iovance Biotherapeutics, Inc. (IOVA) reported gain (loss) on disposition of assets of -$28K in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s gain (loss) on disposition of assets changed year-over-year?
- Iovance Biotherapeutics, Inc.'s gain (loss) on disposition of assets increased by 36.4% year-over-year, from -$44K to -$28K.